reast cancer screening enables early detection of breast cancer which leads to a reduction in mortality.
Data pertaining to characteristics of participants, region of residence, screening mammograms and screening centres are recorded in the program's information system. Characteristics of radiologists were retrieved either from the information system or from the Quebec College of Physicians. 15 Using a validated approach, breast cancers were identified from various sources such as the program's information system, the Quebec physician claims database and the hospitalizations and one-day surgeries data registry. 16 The sensitivity of this approach to identify breast cancer cases was 98.9% and the specificity was 99.7%. Cancer information was available for all women who had a screening mammogram up to 2006. Data confidentiality is maintained through an anonymizing process.
Definition of performance indicators
Participation rate was defined as the proportion of the target population who participated at least once in the program within a twoyear period. It is calculated by dividing the number of women aged 50-69 years who have undergone at least one screening mammography in the program within a two-year period by the mean number of women of similar age in the population during the same period.
Screening mammograms were classified as abnormal if a followup investigation was requested; otherwise it was classified as normal. A cancer was considered "screen-detected" if a ductal carcinoma in situ (DCIS) or an invasive carcinoma was diagnosed within 6 months following an abnormal screen. Screen-detected cancers were considered true-positives at screening. If a cancer (DCIS or invasive) was diagnosed in the 24 months following a normal screen, or if cancer was diagnosed in the 6-24 months interval following an abnormal screen, then such cancers were considered interval cancers (false-negatives). Screening was considered truenegative if cancer was not diagnosed in the 24 months following a normal screen. If a follow-up investigation was requested following an abnormal screen but cancer was not diagnosed in the following 24 months, then the screen was considered false-positive. Table 1 presents the definition of all performance indicators used in our analysis. Sensitivity was defined as the proportion of truepositives among all cancers diagnosed in the 24 months following screening (true-positives/(true-positives + false-negatives)). Detection rate was defined as the number of true-positives per 1,000 screening mammograms. Interval cancer rate was calculated as the number of false-negatives (interval cancers) for 10,000 person-years of follow-up. Person-years were calculated by summing the followup time of each woman screened, excluding the first six months of follow-up after an abnormal screen since all cancers diagnosed during this period are considered screen-detected and thus, women are not "at risk" of interval cancer. A small proportion (6.5%) of women has an annual screening; since follow-up is less than 2 years at the time of the early screen in these women, sensitivity may be slightly overestimated.
False-positive rate (1-specificity) was defined as the proportion of abnormal screens among screens without a cancer diagnosis in the following 24 months (false-positives/(false-positives + truenegatives)). Abnormal call rate was defined as the proportion of all women screened who are referred for follow-up investigation.
Positive likelihood ratio was equal to sensitivity/false-positive rate. Positive predictive value was defined as the proportion of true positives among all abnormal screens. Additional indicators were calculated for screen-detected cancers (true-positives) such as the proportion of in situ cancers among all true-positives, the proportion of invasive cancers less than 1 cm among all invasive truepositives, and the proportion of invasive cancers without nodal invasion among all invasive true-positives.
Analysis
The proportion of all screening examinations carried out in mobile units. This percentage can be interpreted as the percentage of the total participation rate in the region that is attributable to mobile units: (total participation rate -participation rate of fixed centres)/total participation rate. The participation rate of fixed centres corresponds to an estimate of the participation rate that is achieved in this population in the absence of mobile units. However, it must be noted that even in regions without fixed centres, this rate is not zero because some women do travel outside their region to have a mammogram.
To compare performance indicators of mobile units and fixed centres, we used multivariate Poisson regression with robust standard errors to estimate adjusted rate ratios. 17 Poisson regression was chosen since log-binomial models would not converge even after using the COPY method. 17 To respect the multi-level structure of the data and to account for a potential correlation between mammograms interpreted by the same radiologist, models were constructed with generalized estimating equations (GEE) with an independent working correlation matrix. 17 Adjusting for correlation between repeated examinations for the same woman has been shown previously to have little to no effect. 18, 19 A model was constructed for each performance indicator. Models were adjusted for age, parity, family history of breast cancer, breast density, body mass index (BMI), previous breast aspiration or biopsy, use of hormone-replacement therapy (HRT) and screening round (initial mammogram in the program without a previous mammogram; initial mammogram in the program with a previous mammogram; subsequent mammogram in the program with ≤18 months, 19-30 months and >30 months delay from the previous mammogram). Radiologist characteristics were considered intermediate variables and were not included in the main models.
However, complementary analyses were performed by adjusting simultaneously for characteristics related to women and for radiologist characteristics (sex, year of radiology certification, and annual interpretive volume) to examine the effect of adjusting for radiologists' characteristics on estimates. Statistical analyses were conducted with SAS version 9.2 (SAS Institute, Inc., Cary, NC). Contribution Table 2 . Women who had their mammogram in mobile units had a lower risk of breast cancer. Except for a higher BMI, they less frequently had a family history of breast cancer, lower breast density, more children, and less HRT usage. In addition, there were more initial screens among these women than among those participating in fixed centres. Compared to radiologists working in fixed units, radiologists reading mammograms from mobile units were more often male, with greater seniority and a higher annual screening volume.
RESULTS

Contribution of mobile mammography units to the participation rate
Mobile units had similar sensitivity when compared to fixed centres (rate ratio = 0.98 [0.84-1.15]) and a lower false-positive rate, but these differences were of marginal statistical significance (rate ratio = 0.76 [0.57-1.02], (p=0.07)) ( Table 3 ). Since sensitivity remained unchanged while the false-positive rate decreased, it follows that the positive likelihood ratio was higher for mobile units Characteristics of cancers detected in mobile units were comparable to those detected in fixed centres ( 
Complementary analyses
Adjustment for radiologist characteristics attenuated some of the observed differences between mobile units and fixed centres. 
DISCUSSION
Effectiveness, efficiency and equity are key considerations for policymaking in health services. 20 This study provided data on effectiveness and equity. In regions without fixed centres, mobile units facilitated access to screening and bolstered the participation rate by more than 80%. They helped women achieve participation rates comparable to or higher than those of regions serviced by fixed centres. In regions with fixed centres, mobile units also improved equity of access by alleviating temporary problems with fixed centre availability (equipment failure or long waiting lists) and thus contributed to the reduction of waiting lists and delays.
The improvement in equity was observed without loss of effectiveness. Sensitivity for mobile units was comparable to fixed centres while the false-positive rate was slightly improved. After adjustment for radiologists' characteristics, differences noted in the false-positive rate between mobile units and fixed centres decreased. Thus, radiologists' characteristics such as greater seniority and greater annual screening volume appear to explain, at least in part, the lower false-positive rate observed in mobile units. In regions lacking fixed centres, the proportion of native women is greater than that in regions with fixed centres. This might explain why women seen in mobile centres have higher BMI, lower breast density, and higher number of children than women seen in fixed centres. In a Canadian cohort study involving 141,290 First Nations women, the incidence of breast cancer was much lower in these women than in the rest of the population (RR = 0.54). 21 Given equal sensitivity, a group of women with a low incidence rate would tend to have lower detection and interval cancer rates than a group with higher incidence. Thus, differences in ethnicity could explain, at least in part, the lower detection rate and interval cancer rate observed in mobile units compared to fixed centres.
Performing screening mammograms in mobile units presents several challenges. Film developing in analogue units is deferred, the quality of the image (positioning, artefact, compression and contrast) cannot be verified onsite, film quality must be maintained during transportation, and units may require frequent calibration. In addition, work conditions for technologists differ from fixed centres, i.e., high number of screenings in a short period of time, longer working hours and extended periods away from home. To address these challenges, the film-developing process in mobile units follows a rigorous protocol and mammogram quality is systematically verified by the accreditation process. Mobile units in Quebec are now converted to digital units, which should permit real-time treatment of mammograms, including repeating the mammogram, if necessary. Moreover, technologists who do the mammograms and the radiologists who read them are chosen from among those with greater experience in mammography. This study shows that, despite the challenges, the performance of mobile units is equivalent to or slightly better than the performance of fixed centres.
Regarding efficiency, the costs per mammogram performed in mobile units in the Quebec screening program were not studied here but they are likely to be higher than those of fixed centres. for assessment. In addition, the units have to be hauled across the province to reach remote destinations, and medical personnel need to be transported to the unit and work longer hours. Indeed, a study published in 2009 reported higher annual costs for analogue mobile units compared to fixed sites. 10 Although digital units can potentially reduce costs due to reduction in expenses for film processing, the authors reported that the annual operating costs for digital mobile units were greater than for fixed centres.
10 Some studies have shown that mobile units could be more cost efficient if they targeted hard-to-reach populations and maintained high mammography volumes. [22] [23] [24] Strengths of this study include the fact that it is one of the first to compare the performance of mobile units to fixed centres. Previous articles had reported only on the increase in participation rate attributed to mobile units. [5] [6] [7] Concerning the other performance indicators, data have been reported in a few articles but the results were limited to mobile units and were not compared to fixed centres. 8, [12] [13] [14] This population-based study utilized routine followup data collected for women participating in the same screening program. Comparisons between mobile units and fixed centres were conducted for several key performance indicators while taking into account a broad range of potential confounding factors. This study also has some limitations. First, the low number of cancers detected in mobile units limits the statistical power for the analysis of sensitivity. Second, it was not possible to differentiate native from non-native women and this could explain in part the differences observed in the detection rate and interval cancer rate. However, it should have little or no effect on findings for sensitivity and false-positive rate because these indicators are not affected by underlying incidence differences and we were able to adjust for key confounding factors such as age, BMI, breast density and HRT use.
In conclusion, while mobile mammography units may be more costly than stationary centres, in this program, they play a major role in ensuring access to breast cancer screening and guarantee adequate participation rates in regions deprived of a fixed centre. Mobile units also provide an important supporting function in regions where a fixed centre's resources are temporarily insufficient. Moreover, despite the operational differences between fixed and mobile services, screening sensitivity in mobile units is comparable to that of fixed centres with a slight improvement in the falsepositive rate.
